featured
CYP2C8*3: A Protective Factor Against Post-ERCP Pancreatitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical Gastroenterology and Hepatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Heterozygous variant of CYP2C8*3 is a protective factor for developing post-ERCP pancreatitis
Clin. Gastroenterol. Hepatol. 2024 Dec 14;[EPub Ahead of Print], MJ de Jong, RN Kuipers, JP Drenth, RH Te Morsche, F van Delft, PD SiersemaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.